Immunology Flashcards
Alemtuzumab
Therapeutic antibody, cancer therapy
Targets CD52
Use in CLL
Bevacizumab
Therapeutic antibody, cancer therapy
Targets VEGF
Colorectal cancer, renal cell carcinoma
Cetuximab
Therapeutic antibody, cancer therapy
Targets EGFR
Stage IV colorectal cancer, head and neck cancer
Rituximab
Therapeutic antibody, cancer therapy
Targets CD20
B-cell non-Hodgkin lymphoma, rheumatoid arthritis (with MTX), ITP
Trastuzumab
Therapeutic antibody, cancer therapy
Targets HER2/neu
Breast cancer, gastric cancer
Infliximab
Therapeutic antibody, autoimmune disease therapy
Targets TNF-α
IBD, rheumatoid arthritis, ankylosing spondylitis, psoriasis
Adalimumab
Therapeutic antibody, autoimmune disease therapy
Targets TNF-α
IBD, rheumatoid arthritis, ankylosing spondylitis, psoriasis
Natalizumab
Therapeutic antibody, autoimmune disease therapy
Targets α4-integrin (leukocyte adhesion)
Multiple sclerosis, Crohn disease
Risk of PML in patients with JC virus
Abciximab
Therapeutic antibody
Targets glycoprotein IIb/IIIa
Anti-platelet agent for prevention of ischemic complications in patients undergoing percutaneous coronary intervention.
Denosumab
Therapeutic antibody
Targets RANKL, mimics osteoprotegrin
Osteoporosis (inhibits osteoclast maturation)
Digoxin immune Fab
Therapeutic antibody
Antidote for digoxin toxicity
Omalizumab
Therapeutic antibody
Targets IgE. Prevents IgE binding to FcεRI
Allergic asthma.
Palivizumab
Therapeutic antibody
Targets RSV F protein
RSV prophylaxis in high-risk infants
Cyclosporine
Immunosuppressant
Calcineurin inhibitor. Binds cyclophilin. Blocks T cell activation by preventing IL-2 transcription.
Transplant rejection prophylaxis, psoriasis, rheumatoid arthritis
Nephrotoxicity, hypertension, hyperlipidemia, hyperglycemia, tremor, hirsutism, gingival hyperplasia
Tacrolimus
Immunosuppressant
Calcineurin inhibitor. Binds FK506 binding protein (FKBP). Blocks T cell activation by preventing IL-2 transcription
Transplant rejection prophylaxis
Similar to cyclosporine; nephrotoxicity, increased risk of diabetes and neurotoxicity. No gingival hyperplasia or hirsutism
Sirolimus (Rapamycin)
Immunosuppressant
mTOR inhibitor. Binds FKBP. Blocks T cell activation and B cell differentiation by preventing IL-2 signal transduction
Kidney transplant rejection prophylaxis, drug-eluting stents. Synergistic with cyclosporine.
Anemia, thrombocytopenia, leukopenia, insulin resistance, hyperlipidemia, non-nephrotoxic.
Basiliximab
Immunosuppressant
Monoclonal antibody to IL-2R
Kidney transplant rejection prophylaxis
Edema, hypertension, tremor
Azathioprine
Immunosuppressant
Antimetabolite precursor of 6-mercaptopurine. Inhibits lymphocyte proliferation by blocking nucleotide synthesis
Transplant rejection prophylaxis, rheumatoid arthritis, Crohn disease, glomerulonephritis, other autoimmune conditions
Leukopenia, anemia, thrombocytopenia, toxicity increased by allopurinol
Glucocorticoids
Immunosuppressant
Inhibits NF-κB. Suppresses both B and T cell function by decreasing transcription of many cytokines.
Transplant rejection prophylaxis (immune suppression), many autoimmune disorders, inflammation
Hyperglycemia, osteoporosis, central obesity, muscle breakdown, psychosis, acne, hypertension, cataracts, peptic ulcers (iatrogenic Cushing syndrome).
Epoetin alfa
Recombinant cytokine
EPO
Anemias, especially in renal failure
Thrombopoietin
Recombinant cytokine
Thrombocytopenia
Oprelvekin
Recombinant cytokine
Interleukin-11
Thrombocytopenia
Filgrastim
Recombinant cytokine
Granulocyte colony-stimulating factor
Recovery of bone marrow
Sargramostim
Recombinant cytokine
Granulocyte-macrophage colony-stimulating factor
Recovery of bone marrow
Aldesleukin
Recombinant cytokine
Interleukin-2
Renal cell carcinoma, metastatic melanoma
IFN-α
Recombinant cytokine
Chronic hepatitis B and C, Kaposi sarcoma, hairy cell leukemia, condyloma acuminatum, renal cell carcinoma, malignant melanoma
IFN-β
Recombinant cytokine
Multiple sclerosis
IFN-γ
Recombinant cytokine
Chronic granulomatous disease